Advances and challenges in CAR-T cell-mediated immunotherapy

Int Rev Immunol. 2022;41(6):565-566. doi: 10.1080/08830185.2022.2111107.

Authors

Dipayan Rudra¹, Himanshu Kumar²

Affiliations

¹ Section Editor, International Reviews of Immunology, School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
² Editor-in-Chief, International Reviews of Immunology & Principal Investigator, Laboratory of Immunology and Infectious Disease Biology, Indian Institute of Science Education and Research (IISER), Bhopal, India.

PMID: 36256680
DOI: 10.1080/08830185.2022.2111107

No abstract available

Publication types

Editorial

MeSH terms

Humans
Immunotherapy*
Immunotherapy, Adoptive
Neoplasms* / therapy
Receptors, Antigen, T-Cell / genetics
T-Lymphocytes

Substances

Receptors, Antigen, T-Cell